Over the past decade, the basic pharmaceutical products and preparations manufacturing output in Mexico has shown significant growth. In 2023, the output stood at 405.66 billion Mexican Pesos. The year-on-year growth between 2022 and 2023 was 2.35%, showcasing a slowdown compared to the robust 12.65% growth in the prior year. However, recent five-year trends indicate a solid average annual growth rate (CAGR) of 6.98%, underscoring consistent expansion in the sector.

Future trends forecast an annual average growth rate (CAGR) of 1.71% over the next five years, resulting in a cumulative growth rate of 8.83% by 2028. This suggests a moderate growth trajectory, reflecting a stable yet slower pace of expansion compared to the previous period.

Future trends to watch for include:

Impact of regulatory changes and policies on production and export capabilities.
Advancements in pharmaceutical technologies and R&D investments.
Market dynamics influenced by global health crises and changing demand for pharmaceuticals.
Strategic partnerships and mergers within the industry to enhance competitiveness.
Economic factors such as inflation and currency fluctuations impacting cost structures.